While the stable loss of either RAL in the TNBC MDA-MB-468 cell line was associated with increased viability in vitro, the loss of either RAL significantly decreased tumor growth following orthotopic injection into immunocompromised mice. The gene discussed is RALA; the disease is neoplasm.